Chronic obstructive pulmonary disease and cerebral Microbleeds the Rotterdam study

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 7, 2013, Pages 783-788

  Lahousse, Lies ^a,b   Vernooij, Meike W ^c   Darweesh, Sirwan K L ^b   Akoudad, Saloua ^b,c   Loth, Daan W ^b,d   Joos, Guy F ^a   Hofman, Albert ^b,e   Stricker, Bruno H ^b,d,e   Ikram, M Arfan ^b,c   Brusselle, Guy G ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Department of Radiology ^*  (Netherlands)

^d Inspectorate of Health Care   (Netherlands)

^e Netherlands Center for Healthy Ageing   (Netherlands)

Author keywords

Chronic airflow obstruction; Deep or infratentorial cerebral microbleed; Magnetic resonance imaging; Strictly lobar cerebral microbleed; Verebral small vessel disease

Indexed keywords

AGED; AIRFLOW; ARTICLE; BRAIN HEMORRHAGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84886263214     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201303-0455OC     Document Type: Article

References (31)

1. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011;378:1015-1026.
2. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
3. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
4. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010;35:913-922.
5. Beauchamp MK, Sibley KM, Lakhani B, Romano J, Mathur S, Goldstein RS, Brooks D. Impairments in systems underlying control of balance in COPD. Chest 2012;141:1496-1503.
6. Eisner MD, Blanc PD, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med 2008;121:789-796.
7. van Dijk EJ, Vermeer SE, de Groot JC, van de Minkelis J, Prins ND, Oudkerk M, Hofman A, Koudstaal PJ, Breteler MM. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2004;75:733-736. (Pubitemid 38526685)
8. Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton R.A., Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med 2012;186:240-245.
9. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Launer LJ, Van Buchem M.A., Breteler MM; Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165-174.
10. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, Hartung HP. Histopathologic analysis of foci of signal loss on gradient-echo T2-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637-642. (Pubitemid 30429021)
11. Poels MM, Ikram M.A., van der Lugt A, Hofman A, Krestin GP, Breteler MM, Vernooij MW. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke 2011;42:656-661.
12. Vernooij MW, van der Lugt A, Ikram M.A., Wielopolski PA, Niessen WJ, Hofman A, Krestin GP, Breteler MM. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008;70: 1208-1214. (Pubitemid 351482572)
13. Hofman A, van Duijn CM, Franco OH, Ikram M.A., Janssen HL, Klaver CC, Kuipers EJ, Nijsten TE, Stricker BH, Tiemeier H, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011;26:657-686.
14. Ikram M.A., van der Lugt A, Niessen WJ, Krestin GP, Koudstaal PJ, Hofman A, Breteler MM, Vernooij MW. The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol 2011;26:811-824.
15. Lahousse L, van den Bouwhuijsen QJ, Loth DW, Joos GF, Hofman A, Witteman JC, van der Lugt A, Brusselle GG, Stricker BH. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Am J Respir Crit Care Med 2013;187: 58-64.
16. Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, Calverley PM.A., Chavannes N, Dillard T, Fahy B, et al.; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23: 932-946.
17. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720-735. (Pubitemid 41448672)
18. Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS, Massaro JM, DeCarli C. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004;35: 1831-1835. (Pubitemid 38971860)
19. Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999;52:991-994. (Pubitemid 29161609)
20. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist S.A., Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al.; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.AmJ RespirCrit CareMed 2007;176:532-555. (Pubitemid 47403272)
21. Poels MM, Vernooij MW, Ikram M.A., Hofman A, Krestin GP, van der Lugt A, Breteler MM. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 2010;41(10 Suppl):S103-S106.
22. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
23. Poels MM, Zaccai K, Verwoert GC, Vernooij MW, Hofman A, van der Lugt A, Witteman JC, Breteler MM, Mattace-Raso FU, Ikram M.A.. Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study. Stroke 2012;43:2637-2642.
24. Agustí A, Vestbo J. Current controversies and future perspectives in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;184:507-513.
25. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Nordestgaard BG. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186:975-981.
26. Johannessen A, Nilsen RM, Storebo M, Gulsvik A, Eagan T, Bakke P. Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med 2013;188:51-59.
27. Agusti A, Hurd S, Jones P, Fabbri L, Martinez F, Vogelmeier C, Vestbo J, Rodriguez-Roisin R. Frequently asked questions (FAQs) about the GOLD 2011 assessment proposal of COPD. Eur Respir J (In press)
28. Liao D, Higgins M, Bryan NR, Eigenbrodt ML, Chambless LE, Lamar V, Burke GL, Heiss G. Lower pulmonary function and cerebral subclinical abnormalities detected byMRI: the Atherosclerosis Risk in Communities study. Chest 1999;116:150-156. (Pubitemid 29340276)
29. Maclay JD, McAllister DA, Mills NL, Paterson FP, Ludlam C.A., Drost EM, Newby DE, Macnee W. Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:513-520.
30. Garcia-Aymerich J, Gómez FP, BenetM, Farrero E, Basagaña X, Gayete A, Paré C, Freixa X, Ferrer J, Ferrer A, et al.; PAC-COPD Study Group. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011;66:430-437.
31. Gould GA, Redpath AT, Ryan M, Warren PM, Best JJ, Flenley DC, MacNee W. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J 1991;4:141-146.